The long-term clinical effects of wartime traumatic brain injuries (TBIs), most of which are mild, remain incompletely described. Current medical disability cost estimates from world conflicts continually surpass projections. Additional information regarding long-term functional trajectory is needed to reduce this extensive public health burden.
T raumatic brain injury (TBI) affects roughly 3.5 million individuals annually in the United States, 1 and approximately 75% of TBIs are attributable to mild or concussive events. 2 An estimated 20% of the deployed US military suffered a head injury in the wars in Iraq and Afghanistan 3 ;
83.3% endured a mild, uncomplicated TBI or concussion. [4] [5] [6] Compared with civilians, service members with TBI have a high rate of comorbid mental health conditions. Previous studies 7 found that 89% of veterans diagnosed with TBI also had a psychiatric diagnosis, with the median cost of health care in these comorbid cases being 4 times that of veterans with psychiatric diagnosis without TBI. Although civilian studies 8 have reported poor outcomes on the Extended Glasgow Outcome Scale (GOS-E) in 22% to 33% of patients with mild TBI, reports of mild TBI sustained in combat have identified 62% to 96% with poor outcomes on the same measure.
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The long-term clinical effects of wartime injuries remain incompletely described. 13, 14 Previous studies [15] [16] [17] [18] have been based largely on self-report and screening tools to define TBI, rather than direct clinical assessments in cohorts identified at the time of injury and prospectively studied. Although much effort has been expended to better understand this type of concussive TBI, many studies in active-duty US military and veterans 16, [19] [20] [21] [22] [23] [24] [25] [26] have been restricted to cross-sectional evaluations, often involving retrospective medical record review [19] [20] [21] or self-report 16, 18, [22] [23] [24] 26, 27 and considering only later stages of injury. 25, 28 In contrast, our group was provided the unique opportunity to examine patients in the acute 9,29 to subacute 10-12,30 stage after combat-related concussive TBI with prospective follow-up to 1-year 9-12,30 and now 5-year evaluations. This longitudinal observation has allowed for a greater appreciation of functional postinjury trajectory and the effect on longterm outcome. The present study objective was to examine 5-year clinical outcomes leveraged with existing early clinical data in the same patients. Our goal was to identify predictors of poor outcome in service members diagnosed with concussive blast TBI. Given the extraordinary effect of these wartime injuries on service members, their families, communities, and the health care delivery system, we have an imperative to determine factors that will aid in identifying those at risk to better target treatments and therapies, providing proactive resolutions to this potentially high-cost and lifelong health burden.
Methods
Participants were originally enrolled in 1 of 4 previous cohorts. [9] [10] [11] [12] 29, 30 The present study is the 5-year evaluation in a continued prospective, observational, longitudinal research study. We report the 5-year clinical outcomes compared with 1-year findings in the following participant groups: patients with concussive blast TBI and combat-deployed control individuals. This study was approved by the institutional review boards of the University of Washington, Seattle, and the US Army Medical Research Materiel Command and was performed in accordance with the approved protocol. All participants provided additional written informed consent for the 5-year evaluation; no surrogate consent was allowed (eMethods in the Supplement). Selection and enrollment for the 5-year evaluation focused on individuals who had been enrolled at the time of injury, completed the 1-year evaluation, and were at a minimum of 4 years past the original enrollment. Inclusion criteria are reported elsewhere.
9,10,30 In brief, participants were service members deployed to combat from November 1, 2008, through July 1, 2013, for whom original enrollment was completed directly in Afghanistan 9,29 or after medical evacuation to Landstuhl Regional Medical Center in Landstuhl, Germany. 10-12,30 Diagnosis of head injury was determined by trained medical personnel working in the TBI clinics in Germany. For the concussive blast TBI group, all available clinical histories indicated blast exposure plus another mechanism of head injury, such as a fall, motor vehicle crash, or being struck by a blunt object. All patients with concussive blast TBI were evacuated to Germany, and their cases met the Department of Defense definition of mild, uncomplicated TBI. None had a prior TBI or psychiatric diagnosis in their medical records. All combat-deployed controls were found in clinical evaluation to be free of TBI signs and symptoms, and we reviewed their medical records to confirm no history of TBI diagnosis, psychiatric diagnosis, or blast exposure. Combatdeployed controls were enrolled directly in Afghanistan or after evacuation to Germany for noncombat diagnoses such as gastrointestinal tract issues or dermatitis. Subgroup analysis by evacuation status in the control group identified no differences in any of the clinical outcome measures, 10 and the data were combined for this study.
Clinical Assessments
In-person clinical evaluations at the University of Washington included a structured neurobehavioral interview, neuropsychological battery consisting of 10 cognitive tests, and structured psychiatric evaluation identical to the 1-year follow-up with additional self-administered questionnaires. The CAPS was scored using the rules from Blake et al.
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Statistical Analysis
Data were analyzed from October 1 through November 30, 2016. Group differences in patient characteristics were assessed using the 2-sided Fisher exact and Mann-Whitney U tests as appropriate. Group differences in the 5-year outcome were evaluated using standard linear and logistic regression with adjustment for imbalances in patient characteristics. Extension of the 5-year outcome analyses to adjust for the corresponding 1-year outcome was performed using linear and logistic mixed-effects regression modeling, with random intercepts and slopes for each participant and an unstructured correlation matrix. Risk factors for a poor 5-year outcome were determined using multivariate logistic regression modeling based on TBI diagnosis, demographic characteristics, and 1-year clinical outcome data using the Akaike information criterion 50 to determine the optimal combination of variables. The number of events per variable for the best Akaike information criterion model was 8, which although lower than the minimum recommended number (10-15), is likely valid given the conditions of this particular analysis. 51 The area under the receiver operating characteristic curve was calculated to assess model predictive accuracy.
Results
In 
Global Outcome
Patients with concussive blast TBI fared worse on global outcome measures as evidenced by the GOS-E and the Quality of Life After Brain Injury questionnaire at the 5-year follow-up (both adjusted P < .001) ( Figure 1 ). Good outcome for the GOS-E was defined as a score of 7 or 8, with 6 or lower considered to be a poor outcome. Five combat-deployed controls (11%) met this criterion, whereas 36 patients with concussive blast TBI (72%) were found to also have poor outcomes ( Figure 1A ). Comparing 1-year with 5-year GOS-E scores in the same participant, 5 combat-deployed controls (11%) had experienced decline by their 5-year evaluation. In contrast, 36 patients who experienced concussive blast TBI (72%) declined into or further in the moderate to severe disability range. A small subset in each cohort (10 patients with concussive blast TBI [20%] and 15 combat-deployed controls [34%]) improved, defined as a 1-year GOS-E score of 6 or less and a 5-year GOS-E score of 7 or 8. Many participants reported a significant effect on quality of life as observed in Figure 1B ; 6 combat-deployed controls (14%) and 23 patients with concussive blast TBI (46%) scored in the bottom 3 categories of no to moderate life satisfaction (adjusted P < .001).
Neurobehavioral Evaluation
The patients with concussive blast TBI had significantly elevated levels of neurobehavioral symptoms (unadjusted mean [SD], 5 [4] ) compared with combat-deployed controls at their 5-year evaluation (unadjusted mean [SD], 14 [7] ; adjusted Figure 2B ). Headache impairment was worse in the concussive blast TBI group (adjusted P < .001) ( Figure 2C ). With use of the clinical cutoff of 11 for Migraine Disability Assessment scores and 50 for Headache Impact Test scores, moderate to severe headache impairment was observed in 10 combatdeployed controls (23%) and 31 patients with concussive blast TBI (62%) on the Migraine Disability Assessment and in 19 combat-deployed controls (43%) and 43 patients with concussive blast TBI (86%) on the Headache Impact Test. No participant reported a TBI diagnosis since the 1-year evaluation on the history of head injury in the intake interview. Seven combatdeployed controls (16%) and 27 patients with concussive blast TBI (54%) endorsed events suggestive of concussion, although few sought medical attention. These events were primarily ground-level falls and hits to the head during training exercises for combat-deployed controls and fights and motor vehicle crashes for patients with concussive blast TBI.
Neuropsychological Performance
Cognitive performance was tested across 10 domains of function (eTable 1 in the Supplement 
CombatDeployed Controls
A, Global disability was assessed using the Extended Glasgow Outcome Scale (GOS-E; scores range from 3-8, with 7 or 8 categorized as a good outcome and Յ6 categorized as a poor outcome). Five controls (11%) and 36 patients with concussive blast traumatic brain injury (TBI) (72%) had a poor outcome. B, Overall life satisfaction was assessed using the Quality of Life After Traumatic Brain Injury (QOLIBRI; range, 6-30, with higher scores indicating greater life satisfaction). Each data marker represents an individual; horizontal black lines, mean (SD). 
Psychiatric Evaluation
Mental health symptoms in multiple domains were significantly elevated in patients with concussive blast TBI compared with combat-deployed controls at the 5-year evaluation. Symptoms of posttraumatic stress measured by structured interview (CAPS) and self-report (PTSD ChecklistMilitary Version) were significantly more severe in patients with concussive blast TBI (adjusted P < .001 for both) ( Figure 3A) . Severity of depressive symptoms measured by structured interview (MADRS) and self-report (Beck Depression Inventory) was similarly disparate across groups (adjusted P = .001 for both) ( Figure 3B ). Using the clinical cutoffs of 65 for CAPS and 20 for MADRS, we found that 4 combat-deployed controls (9%) met the criteria for moderate to severe PTSD and 6 (14%) for moderate to severe depression. In contrast, 24 patients with concussive blast TBI (48%) had moderate to severe PTSD and 20 (40%) had moderate to severe depression. When comparing the 1-and 5-year PTSD data in the same participant, 9 combat-deployed controls (21%) and 19 patients with concussive blast TBI (38%) scored more than 10 points worse on the CAPS at their second evaluation. Both groups had roughly 20% with substantial exacerbation in depression defined as greater than a 10-point increase on the MADRS during this period (8 combat-deployed controls [18%] and 10 patients with concussive blast TBI [20%]). The groups also significantly differed on measures of anxiety (adjusted P = .001) and sleep impairment (adjusted P = .003), whereas no significant difference was observed in alcohol misuse (adjusted P = .23) ( Figure 3C-E) . Using the clinical cutoffs of 7 for the anxiety module of the Brief Symptom Inventory and 15 for the Insomnia Severity Index (sleep impairment measure), 6 combat-deployed controls (14%) and 27 patients with concussive blast TBI (54%) had moderate to severe anxiety symptoms, and 9 combat-deployed controls (20%) and 28 patients with concussive blast TBI (56%) had moderate to severe sleep impairment. Of interest, between the 1-and 5-year study evaluations, 18 combat-deployed controls (41%) and 40 patients with concussive blast TBI (80%) endorsed seeking assistance from a licensed mental health care professional, defined as a psychologist, psychiatrist, therapist, social worker, or other licensed, credentialed mental health care professional. Only 9 combat-deployed controls (20%) and 9 patients with concussive blast TBI (18%) reported that the mental health programs helped.
Predictors of Poor Outcome
We used the 1-year clinical outcome data to determine what demographic, neurologic, neuropsychological, and psychiatric factors, including interim head impact exposures best predicted 5-year poor global outcome, defined as a GOS-E 
CombatDeployed Controls
A, Overall neurobehavioral symptom severity was assessed using the Neurobehavioral Rating Scale-Revised (NRS; scores range from 0-33, with higher scores indicating more symptoms; maximum score, 87). B, Focal neurologic deficits were assessed using the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI; scores range from 0-6, with higher scores indicating more deficits; maximum score, 58). C, Headache impairment was assessed using the Migraine Disability Scale (MIDAS; scores range from 0-110, with higher scores indicating more headache disabiltiy; maximum score, 270) and the 6-item Headache Impact Test (HIT-6; scores range from 36-78, with higher scores indicating more headache impairment; maximum score, 78). TBI indicates traumatic brain injury. Each data marker represents an individual; horizontal black lines, mean (SD).
Clinical Predictors of 5-Year Outcome After Concussive Blast Traumatic Brain Injury
Original Investigation Research jamaneurology.com (Reprinted) JAMA Neurology July 2017 Volume 74, Number 7 825 score of 6 or less (moderate to severe disability). Of the 94 participants, 84 had complete 1-year clinical outcome data that were used for analysis. Logistic regression using dichotomized GOS-E of 7 to 8 (good outcome) and 6 or less (poor outcome) identified the best-fit model by Akaike information criterion to include TBI diagnosis, neurobehavioral symptom severity (a 29-domain measure of neurologic, cognitive, and mental health function), performance on a 7.5-m (25-ft) walk (motor strength, balance, and coordination), performance on the Wechsler Test of Adult Reading 
CombatDeployed Controls
A, Posttraumatic stress disorder (PTSD) severity was assessed using the Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (CAPS; scores range from 0-117, with higher scores indicating greater PTSD severity; maximum score, 136) and the self-administered PTSD Checklist-Military Version (PCL-M; scores range from 17-76, with higher scores indicating greater PTSD severity; maximum score, 85). B, Depression severity was assessed using the Montgomery-Asberg Depression Rating Scale (MADRS; scores range from 0-40, with higher scores indicating greater depression severity; maximum score, 60) and the self-administered Beck Depression Inventory (BDI; scores range from 0-40, with higher scores indicating greater depression severity; maximum score, 63). C, Anxiety symptom severity was assessed using the anxiety module of the Brief Symptom Inventory (BSI; scores range from 0-18, with higher scores indicating greater anxiety severity; maximum score, 24). D, Severity of poor sleep assessed using the Insomnia Severity Index (ISI; scores range from 0-28, with higher scores indicating worse sleep impairment; maximum score, 28). E, Alcohol misuse was assessed using the Michigan Alcoholism Screening Test (MAST; scores range from 0-15, with higher scores indicating greater alcohol impairment; maximum score, 22). TBI indicates traumatic brain injury. Each data marker represents an individual; horizontal black lines, mean (SD); and dashed lines, threshold for moderate to severe symptoms for each evaluation.
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Discussion
These findings indicate that service members who sustained blast concussion in combat have worse early long-term outcomes compared with combat-deployed controls. The rate of disability observed in concussive blast TBI is much higher than in otherwise comparable civilian studies, even in mild TBI with polytrauma, and speaks to a higher percentage of persistent postinjury symptoms in service personnel. 54-61 A substantial number of patients with concussive blast TBI continued to experience decline from the 1-to 5-year evaluations. The historic mantra in medicine regarding general stability at 6 months after injury appears to be challenged in this population, with progression of postconcussive symptoms well after this time frame. Although cognitive performance was not substantially different between patients with concussive blast TBI and combat-deployed controls, considerable disparities in psychiatric symptom severity were observed. Specifically, symptoms of PTSD, depression, and anxiety were significantly elevated in participants with concussive blast TBI, and a substantial number of these individuals were found to have worsening impairment compared with their 1-year assessment. Chronic sleep impairment was also significantly worse in patients with concussive blast TBI. We find the combination of sustained, elevated psychiatric symptoms and sleep impairment concerning, given the growing literature on the long-term health implications of these 2 conditions. Chronic sleep impairment has been reported to affect metabolic and cardiovascular health as well as overall disease-associated mortality. 62 Although our study identified impairment sustained during the course of this first 5-year period after injury, given the young age of these service members (most in their 30s), questions arise regarding how these individuals will progress with natural aging and what health complications they will face in the future. For this reason, we examined predictors of the 5-year outcome leveraging early clinical data collected in the same participant to target modifiable risk factors to reduce the longterm effect of these exposures. By logistic regression, we identified TBI diagnosis, preinjury intelligence, motor strength, verbal fluency, and neurobehavioral symptom severity at 1 year as risk factors for 5-year poor outcomes, with an area under the curve of 0.92 indicating excellent prediction strength. Among these, neurobehavioral symptoms may be a particularly important modifiable target for early intervention in service members with concussion. 
Conclusions
Together these findings indicate progression of symptom severity beyond 1 year after injury. Many service members with concussive blast TBI experience evolution rather than resolution of symptoms from the 1-to 5-year outcomes. Even a small percentage of combat-deployed controls appeared to experience worsening over time. In both groups, this finding appears to be driven more by psychiatric symptoms than by cognitive deficits. Efforts are under way to replicate these findings in a larger cohort and to extend evaluation to later years. These results speak to the need for new approaches to comorbid mental health treatment and long-term care, given that most of the patients in our study (80%) sought help but a much smaller number (19%) found sustained resolution. Targeting psychological health domains identified herein and by others 21,64-69 might provide the highest potential for a long-lasting effect of treatment. This process may aid in reducing the public health burden and extensive cost facing our service members and our nation in the decades to come. Peak disability payout for veterans of world conflicts has been reported to incur decades after the conflict is over. 71 We believe that by being informed from longitudinal studies such as this one, the medical community can be proactive in combatting the potentially negative and extremely costly effect of these wartime injuries.
eMethods. Participant Compensation, Safety and Data Monitoring, and Clinical Evaluations
Participant Compensation
Active duty military subjects were not paid for participation per government guidelines, though travel expenses to the University of Washington in Seattle were covered. Service members who had since separated from the service by the time of this 5-year follow-up were paid $250 for participation plus travel expenses were covered.
Safety and Data Monitoring
Subjects were assigned a random 5-digit code number to protect confidentiality and all research data was identified by code number only. A board-certified psychiatrist (J. Fann) was immediately available in case an evaluation exacerbated mental health symptoms. No exacerbations requiring medical intervention occurred, though additional support from study staff was required on several occasions.
For clinical evaluations, the principal investigator audited 1 in 10 randomly selected subjects' data sets to ensure that data was scored and entered correctly. These audits revealed only minor discrepancies in scoring criteria which were then corrected across the entire cohort of subjects.
Extended Glasgow Outcome Scale
The GOS-E is scored from 1-8: 1=dead, 2=vegetative, 3-4=severe disability, 5-6=moderate disability, 7-8=good recovery. Moderate disability (GOS-E = 5-6) is defined as one or more of the following: 1) inability to work to previous capacity 2) inability to resume much of regular social and leisure activities outside the home 3) psychological problems which have frequently resulted in ongoing family disruption or disruption of friendships. Severe disability (GOS-E = 3-4) is defined as one or more of the following: 1) inability to drive and/or travel locally without assistance 2) inability to shop or run errands without assistance 3) support required for activities of daily living. Standardized, structured interviews were performed per published guidelines. 1 Participants were instructed to consider deployment as the reference point for this interview.
Neuropsychological Test Battery
The neuropsychological test battery consisted of the following: Conner's Continuous Performance Test II 
